Liza C Villaruz

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Tyrosine Kinase

Brain Metastases

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Liza C Villaruz, George R Blumenschein, Gregory A Otterson, Ticiana A Leal
Emerging therapeutic strategies for enhancing sensitivity and countering resistance to programmed cell death protein 1 or programmed death-ligand 1 inhibitors in non-small cell lung cancer. Cancer (2023)
Ryan D Gentzler, Liza C Villaruz, John C Rhee, Bethany Jablonski Horton, Joseph Mock, Michael Hanley, Kyeongmin Kim, Michelle A Rudek, Mitch A Phelps, Michael A Carducci, Richard L Piekarz, Kwon-Sik Park, Timothy N J Bullock, Charles M Rudin
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399. The oncologist (2023)
Pamela N Munster, Nicholas O Iannotti, Daniel C Cho, Joanne M Jeter, Liza C Villaruz, Geoffrey Thomas Gibney, Frank Stephen Hodi, Niharika B Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven J O'Day
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study. Cancer research communications 3 (12) (2023)
Pamela N Munster, Nicholas O Iannotti, Daniel C Cho, Joanne M Jeter, Liza C Villaruz, Geoffrey Thomas Gibney, Frank Stephen Hodi, Niharika B Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven J O'Day
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study. Cancer research communications 3 (12) (2023)
Pamela N Munster, Nicholas O Iannotti, Daniel C Cho, Joanne M Jeter, Liza C Villaruz, Geoffrey Thomas Gibney, Frank Stephen Hodi, Niharika B Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven J O'Day
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study. Cancer research communications 3 (12) (2023)
Pamela N Munster, Nicholas O Iannotti, Daniel C Cho, Joanne M Jeter, Liza C Villaruz, Geoffrey Thomas Gibney, Frank Stephen Hodi, Niharika B Mettu, Mark Jones, Jill Bowman, Michael Smith, Mani Lakshminarayanan, Steven J O'Day
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study. Cancer research communications 3 (12) (2023)